About jera

This author has not yet filled in any details.
So far jera has created 19 blog entries.

Vivere President and CEO, Debbie James, Finalist for Prestigious National Award

Debbie JamesDebbie James, Vivere President and CEO is a finalist for the Entrepreneur Of The Year® 2017 Award in the Southeast.  The awards program, which is celebrating its 31st year, recognizes entrepreneurs who are excelling in areas such as innovation, financial performance and personal commitment to their businesses and communities.

Debbie was selected as a finalist by a panel of independent judges.  Award winners will be announced at a special gala on June 8 at the College Football Hall of Fame in Atlanta, Georgia.

Now in its 31st year, the program has expanded to recognize business leaders in over 145 cities and more than 60 countries throughout the world.

Regional award winners are eligible for consideration for the Entrepreneur Of The Year National competition.  Award winners in several national categories, as well as the Entrepreneur Of The Year National Overall Award winner, will be announced at the Entrepreneur Of The Year National Awards gala in Palm Springs, California, on November 18, 2017. The awards are the culminating event of the Strategic Growth ForumTM, the nation’s most prestigious gathering of high-growth, market-leading companies.

By | June 2nd, 2017|Local News|0 Comments

The Scientific Advisory Board of Vivere (SAB) Awards $45,000 in Grants

Scientific Advisory Board Logo 5Since 2014, the Scientific Advisory Board of Vivere (SAB) has awarded more than $145,000 in grants to 36 fellows practicing in the field of Reproductive Endocrinology and Infertility (REI) at some of the nation’s leading universities.

During the American Society for Reproductive Medicine (ASRM) annual conference, The SAB of Vivere awarded $45,000 in research and travel grants to support continuing education to 13 REI Fellows from prestigious fellowship programs throughout the United States which included:

• Shannel Adams – University of Cincinnati
• Lusine Aghajanova – University of California at San Francisco
• Darcy Broughton – University of St. Louis
• Gretchen Collins – Case Western University
• Randi Goldman – Brigham & Women’s Hospital
• Jacqueline Ho – University of Southern California
• Heather Hoff – University of North Carolina
• Jonathan Kort – Stanford University
• Lynda Mcginnis – University of Southern California
• Jessica Mclaughlin – The University of Texas Health Science Center at San Antonio
• Emily Seidler – Harvard University
• Molly Quinn – University of California at San Francisco
• Irene Woo – University of Southern California

“We are tremendously proud of the impact that our grant recipients have had in the field of fertility,” said Daniel Williams, M.D., SAB Chairman. “Their research projects have helped shape the future of women’s health and reproductive medicine, as well as support our mission to assist residents and fellows to become thought leaders in fertility.”

Most recently, Christina Boots, M.D., recipient of the 2014 SAB Research Grant, has received an impressive amount of interest in her research project on the effects of obesity on female reproductive health and their oocytes or egg cells. Dr. Boots has been published in well-respected publications including Fertility and Sterility (January 2014), Human Reproduction: Oxford Journals (January 2016), and the Journal of Assisted Reproduction and Genetics. (August 2016). In addition, she has as given presentations on her findings at multiple national conferences including ASRM and the Pacific Coast Reproductive Society.

“Papers, being accepted and sponsored by SAB, are being published in high impact, highly regarded scientific journals,” said Michael Thomas, M.D., Professor of Obstetrics and Gynecology and Fellowship and Section Director, Division of Reproductive Endocrinology and Infertility at University of Cincinnati, as well as Scientific Advisory Board Member.

In continuation of support of education, Vivere is also offering two travel grants to attend their March MBA Fertility Series Symposium in Fort Lauderdale, Florida. The symposium was developed as a networking opportunity for fertility physicians and professionals to connect with business and marketing innovators to learn more about the tools and strategies needed for growth. Fellows are encouraged to apply by visiting

By | November 28th, 2016|Local News|0 Comments

Vivere Partners with Resolve: The National Infertility Association on Nationwide Patient Satisfaction Survey

Vivere is proud to partner with Resolve: The National Infertility Association on a patient satisfaction survey focused on learning more about patient expectations when it comes to visiting a fertility medical practice. This will allow Vivere practices, as well as fertility practices throughout the United States, to have more insight on how we can best serve our patients as they’re on their fertility journey.

If you or anyone you know has seen a fertility physician within the last two years, we encourage you to take the survey –

By | November 15th, 2016|Local News|0 Comments

Vivere Awarded Top Ten Designation as One of the Fastest Growing Private Companies in Middle Tennessee

fast50edited-750xx600-338-0-56Vivere was once again named one of the “Fastest Growing Private Company” by the Nashville Business Journal. This is the third year in a row that Vivere has been awarded a Top 15 position.

Each year the Nashville Business Journal (NBJ) compiles a list of the area’s top privately held companies.  From this list, the NBJ selects the Top 50 Fastest Growing Companies in Middle Tennessee based upon their growth over the past three years.  Since launching in 2010, Vivere has more than tripled in size and has a proven track record of creating value for physician partners in the fertility industry.

Globally, Nashville-based healthcare companies generate more than $70 billion in revenue and more than 400,000 jobs.  The healthcare industry is Nashville’s largest and fastest growing employer, directly employing 110,000, an increase of more than 20 percent from 90,000 jobs in 2004.  In the last three years, Vivere has experienced a revenue growth of 119%.

Known for innovation and for being trusted thought-leaders in the industry, Vivere is led by President and CEO Debbie James. “I’m proud to accept this award on behalf of an exceptional team who are dedicated to helping growing fertility practices do more and be more,” said James.

The Vivere team has achieved a track record of developing successful fertility practices in a highly competitive and dynamic market segment.  Now regarded as a thought leader and innovator in the industry, Vivere identifies market growth strategies based on a holistic view of a practice, and then invests and executes on these plans to deliver financial results.


By | September 24th, 2016|Local News|0 Comments

The Scientific Advisory Board of Vivere (SAB) Announces Fellowship Grants

SAB Grants

Since 2014, the Scientific Advisory Board of Vivere (SAB) has awarded more than $100,000 in grants to 23 fellows practicing in the field of Reproductive Endocrinology and Infertility (REI) at some of the nation’s leading universities. The SAB of Vivere is pleased to announce the availability of another $45,000 in research and travel grants to support continuing education for REI fellows.

Three research grants of $10,000 each are available for REI fellows whose work reflects the mission and goals of the SAB of Vivere to bring young people to thought leaders by support of residents/fellows in scientific research and knowledge.

Fellows who will be presenting (oral or poster presentations) at this year’s 2016 American Society of Reproductive Medicine annual meeting in Salt Lake City, Utah, are also eligible to apply for one of 10 $1,500 grants. The grants were designed to help with the cost of registration, travel arrangements and hotel accommodations at the conference. Special consideration will be given to grant applicants that contain business or economic models to improve REI business practices.

“I am so grateful to Vivere’s Scientific Advisory Board of Vivere for awarding me a fellowship research grant,” said Molly Quinn, M.D., University of California, San Francisco, who received a grant last year. “With this funding, I was able to initiate a research project investigating the association between Bisphenol A levels and ovarian aging. I am honored to be presenting preliminary findings at the ASRM annual meeting this fall.”

Jennifer F. Knudtson, M.D., University of Texas Health Science Center at San Antonio, agreed that the SAB of Vivere grant she received last year granted her a unique opportunity to pursue her research goals. “From this research experience, I was able to further my career through presentations, publications and increased my research support. Thank you SAB of Vivere!” she said.

To apply for the grants, please visit our website at and choose “Awards and Grants”. Online application submissions will be accepted until late August. Grant recipients will be announced at the American Society of Reproductive Medicine’s annual meeting in October.

By | August 1st, 2016|Local News|Comments Off on The Scientific Advisory Board of Vivere (SAB) Announces Fellowship Grants

Houston Fertility Institute Gives Hope to Women, Receives Top Forbes Honor in Return

HFIAs more women enter and choose to remain in the workforce while deferring plans to start families, one industry has offered a way to offer the best of both worlds. Egg-freezing was once considered to be a fad procedure. However, in 2012, the American Society for Reproductive Medicine announced “egg-freezing is no longer an experimental procedure.” This practice has now enjoyed a surge in effectiveness and popularity for women and families wishing — or needing — to make future plans for their family safely.

One Houston-based company, Houston Fertility Institute, is one of the most experienced egg-freezing clinics in the nation, and has enjoyed providing numerous successful births to happy parents. The experience and commitment that HFI has shown has resulted in the company being named the number one practice in Texas for egg-freezing, and in the top five in the United States, by Forbes magazine.

“This honor is a testament to our incredible team and family,” said Dr. Jason Yeh, the Director of Patient Education for Houston Fertility Institute. “One of the best feelings in the world is meeting my patient’s new baby and watching them enjoy being parents for the first time.”

The rise in popularity for egg-freezing is attributed to the advances in technology that companies like Houston Fertility Institute have utilized. Women benefiting from this specific technology has been reported in record numbers. In 2009, 475 women opted to freeze their eggs at clinics across the nation. By 2013, that number had grown sevenfold to nearly 4,000 women. Projections state that by 2018 approximately 76,000 women will have their eggs frozen. Today, industry-leading companies such as Apple and Facebook have even added egg-freezing to corporate health plans.

The benefits of egg-freezing

Houston Fertility Institute works in association with Vivere Piney Point Fertility Laboratory, using a cutting-edge procedure called vitrification, where eggs are flash-frozen and capable of being stored indefinitely. Once a patient is ready to pursue pregnancy, the eggs can be thawed and fertilized by in vitro fertilization, and the embryos can be transferred into her uterus. HFI has extensive experience in this procedure, beating the second-ranked Texas clinic’s experience rate at nearly a 10-to-1 ratio.

The need for egg-freezing came from the desire — or in some cases the need — of women and families to put off any attempts to get pregnant until a later time, months or years down the line. But the process goes beyond a matter of convenience. Women undergoing cancer treatment can end up with damaged ovarian functions, and treatments for other medical conditions can also stack the odds against a successful pregnancy. Even the ramifications of the Zika virus — with its possible side effects of birth defects — have even prompted some women to defer starting their families much like it has prompted athletes to give up their coveted spots in the 2016 Summer Games in Rio.

With the lives of future generations of happy families in their hands, the staff at Houston Fertility Institute have worked hard to achieve the Forbes rankings, which were compiled using the Centers for Disease Control and Prevention’s recently released Assisted Reproductive Technology (ART) Success Rates Report.

“Our practice experience has given numerous patients the opportunity to return to us to have their frozen eggs thawed and fertilized,” said Dr. S. Kemi Nurudeen, HFI’s Director of Fertility Preservation. “These women have gone on to experience successful pregnancies with healthy babies, which of course is the ultimate goal.”

By | July 28th, 2016|Local News|Comments Off on Houston Fertility Institute Gives Hope to Women, Receives Top Forbes Honor in Return

Vivere-Audubon Partner Lindsay Wells, M.D. Voted #1 Fertility Doctor!

lindsaywellsVivere congratulates Lindsay Wells, M.D. our physician partner at Vivere-Audubon Surgery Center for being named the #1 Favorite Fertility Physician in Nola Baby & Family Magazine!

Dr. Lindsay Wells and her team are dedicated professionals who provide comprehensive medical management of fertility in a sensitive and ethical manner. Their practice strives to provide a confidential and individualized experience.

Audubon Fertility in partnership with Vivere-Audubon Surgery Center & IVF Lab offers patients a state-of-the-art facility equipped with the latest technology. Its physicians and staff are trained in the latest techniques and therapies in the field of Reproductive Endocrinology & Infertility. Both facilities were designed to reduce patients’ level of stress by providing a convenient and comfortable location and being easily accessible to its patients throughout diagnosis and treatment.

Dr. Wells believes that a successful fertility practice emphasizes education of patients about their diagnosis and treatment process. She also advocates complementing traditional medical approaches with alternative therapies such as yoga and acupuncture.

By | July 13th, 2016|Local News|Comments Off on Vivere-Audubon Partner Lindsay Wells, M.D. Voted #1 Fertility Doctor!

Vivere Partners, Houston Fertility Institute, Named One of the Top Fertility Clinic by Forbes Magazine

By | April 21st, 2016|Industry News|Comments Off on Vivere Partners, Houston Fertility Institute, Named One of the Top Fertility Clinic by Forbes Magazine

Fortune Magazine Names Vivere One of the Fastest Growing Companies in the United States

viv_logo_stack_rgb_lgeVivere is proud to be named one of the 50 fastest-growing women-owned businesses in the United States!  Special congratulations to Debbie James, Vivere President and CEO, for her continued leadership to make Vivere a success.



Exclusive: These Are the 50 Fastest-Growing Women-Owned Businesses

Exclusive: These Are the 50 Fastest-Growing Women-Owned Businesses

By | April 14th, 2016|Uncategorized|Comments Off on Fortune Magazine Names Vivere One of the Fastest Growing Companies in the United States

Vivere Expands Services with Aquisition of Fertility Patient Experience Company

Vivere, a fertility management and equity partner, has acquired Reconceived, LLC, the pioneer in providing patient experience training programs for the fertility industry.

From the initial patient interaction to fertility coaching and financial discussions, Reconceived’s customized and solution-based programming facilitates positive engagement through every step of the patient’s fertility journey. The company’s proven approach has generated as much as a 10 percent increase in patient retention in just six months following program launch.

A rapidly growing company with an expanding pipeline, Vivere’s acquisition of Reconceived is reflective of the company’s holistic view of fertility practice success – clinical, operation, business and patient experience. “This unique perspective, creates a competitive advantage – Vivere partner practices, on average, have achieved 25 percent four-year total cycle volume growth compared to a 14 percent average growth among the practices in the U.S.   Providing strong marketing strategies and an exceptional patient experience are key components to that success,” said Vivere President and Chief Executive Officer Debbie James.  “And we’re so excited to have Reconceived founder Lisa Duran join our senior leadership team as vice president and chief experience officer.”

“IVF patients face remarkably distinct and personal needs, requiring a highly personalized approach that can be difficult to maintain in a physician practice environment,” said Duran. “Vivere not only recognizes that need, but is committed to setting – and consistently raising – the gold standard in fertility patient excellence.”

By | October 16th, 2015|Local News|Comments Off on Vivere Expands Services with Aquisition of Fertility Patient Experience Company